Related Experiment Video
Updated: Jan 14, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Research advance in correlation between childhood asthma and gut microbiota
Yucong Ma1, Haoqi Zheng2, Hai Tian3
1Department of Pediatric Respiratory, Children's Medical Center, The First Hospital of Jilin University, Changchun, China.
Insights
Childhood asthma is linked to gut bacteria. Interventions like probiotics and SCFAs show promise in rebalancing gut microbes and reducing inflammation, offering new treatment avenues.
Area of Science:
- Pediatric Pulmonology
- Microbiome Research
- Immunology
Background:
- Asthma is a common, complex respiratory condition in children.
- The gut-lung axis plays a key role in asthma development.
- Specific gut bacteria, like Lactobacillus and Bifidobacterium, are associated with childhood asthma.
Purpose of the Study:
- To review evidence on the gut-lung axis and childhood asthma.
- To explore the potential of microbiota-targeted therapies for asthma.
- To synthesize findings from human and animal studies.
Main Methods:
- Literature review of clinical and mechanistic studies.
- Analysis of research on gut microbiota, probiotics, SCFAs, and phytogenic compounds.
- Examination of the gut-lung axis in pediatric asthma pathogenesis.
Main Results:
- Gut microbiota modulation shows promise for asthma management.
- Probiotic supplementation and short-chain fatty acids (SCFAs) can restore microbial balance and reduce type 2 inflammation.
- Phytogenic compounds may alter gut microbiota and improve asthma symptoms.
Conclusions:
- Targeting the gut microbiota offers a promising therapeutic strategy for pediatric asthma.
- Further research is needed to develop personalized, microbiota-based interventions.
- Restoring gut microbial homeostasis is crucial for managing childhood asthma.
Abstract:
Asthma remains a highly prevalent and heterogeneous chronic respiratory disease in the pediatric population. Accumulating evidence has established a critical role of the gut-lung axis in the pathogenesis of asthma. Specifically, gut microbiota constituents such as Lactobacillus and Bifidobacterium species have been closely associated with childhood asthma. Current intervention strategies targeting the gut microbiota show considerable promise. Probiotic supplementation and short-chain fatty acids (SCFAs) have demonstrated the ability to restore microbial homeostasis and suppress type 2 inflammation. Additionally, phytogenic compounds exhibit potential in reshaping the gut microbial composition and ameliorating asthma symptoms. This review synthesizes clinical and mechanistic evidence from both human and animal studies, highlighting the translational potential of microbiota-targeted therapies. Future research should prioritize the development of personalized microbiota-based interventions to improve clinical outcomes in children with asthma.
More Related Videos
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...

